Evidence map›Paper›PMID 37370875›Full record

ArticleCancers2023

Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer.

Gwen Schroyen, Jeroen Blommaert, Donatienne van Weehaeghe, Charlotte Sleurs, Mathieu Vandenbulcke, Nina Dedoncker, Sigrid Hatse, An Goris, Michel Koole, Ann Smeets and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Gwen SchroyenLeuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-9646-5106
Jeroen BlommaertLeuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-4746-9688
Donatienne van WeehaegheDepartment of Nuclear Medicine and Molecular Imaging, KU Leuven, 3000 Leuven, Belgium.
Charlotte SleursLeuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-4480-8330
Mathieu VandenbulckeLeuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Nina DedonckerLeuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-5357-8135
Sigrid HatseLeuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-6764-2628
An GorisLeuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-1276-6682
Michel KooleLeuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0001-5862-640X
Ann SmeetsLeuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-5091-6602
Koen van LaereLeuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Stefan SunaertLeuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0002-1177-4680
Sabine DeprezLeuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.ORCID 0000-0001-7451-5355

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original publication [...].

Identifiers

PMID37370875
PMCPMC10296064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.